Transgender Health clinical trials at UCLA
3 research studies open to eligible people
Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection
open to eligible people ages 16 years and up
The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.
Los Angeles, California and other locations
Adaptive Intervention to Facilitate PrEP Uptake/Adherence Among Transgender Women
open to eligible males ages 18 years and up
"PrEP N' Shine" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Transgender women (TGW).
Los Angeles, California
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
open to eligible males ages 16-29
The LifeSkills Mobile app will be evaluated in a randomized controlled trial (RCT) among 5,000 young transgender women (YTW), ages 16-29 in the United States (U.S.). Study findings will demonstrate if the intervention will reduce HIV incidence.
Los Angeles, California
Our lead scientists for Transgender Health research studies include Matthew Mimiaga, ScD, MPH, MA.
Last updated: